Gwenaëlle (Gwen-Eye-Yell) joined LIBD in 2022 as a scientific project manager. Before joining the Lieber Institute, she earned her neurobiology doctorate at Duke University School of Medicine. She completed her dissertation work with Kafui Dzirasa, M.D., Ph.D. and Marc Caron, Ph.D. investigating the role of dopamine in cognitive deficits in schizophrenia and characterizing the behavioral and neurophysiological effects of a novel antipsychotic drug in vivo. Her graduate training included extensive behavioral neuroscience, neuroanatomy, molecular and cellular biology, pharmacology, neuroengineering, and machine learning, in addition to clinical exposure in psychiatry and neurology. While in graduate school, she co-founded BlackInNeuro, a 501(c)(3) non-profit organization, and served as the director of communications. Prior to her studies at Duke University, she earned the Meyerhoff Scholarship and completed a dual degree in Biochemistry and Molecular Biology and Psychology B.S. from the University of Maryland, Baltimore County. Her undergraduate research focused on elucidating schizophrenia pathophysiology and applied bioinformatics, animal behavior, genetics, and neuroengineering.